GreenDot Stocks
Back to screen

Cellebrite DI (CLBT)

Generated: July 25, 2026
Green Dot

Statistics

MetricValue
Last Close$14.75
Blended Price Target15.86
Blended Margin of Safety7.5% Fairly Valued
Rule of 40 (Next)46.9%
Rule of 40 (Current)48.3%
FCF-ROIC29.3%
Sales Growth Next Year17.6%
Sales Growth Current Year19.0%
Sales 3-Year Avg19.1%
IndustrySoftware - Infrastructure

Analysis

Cellebrite DI looks like a high‑quality, durable software business anchored by mission‑critical products and a strongly recurring revenue base.[1][6] Its revenue growth has remained in the high‑teens to low‑20s range recently, and management’s 2026 guidance implies continued double‑digit expansion, suggesting a growth profile that is above typical mature software peers.[1][7] The combination of strong gross margins, positive net income, and robust free cash flow indicates a business model that is already financially mature rather than speculative.[1][6]

Revenue predictability appears very high, with subscription and other recurring streams dominating the mix and Annual Recurring Revenue (ARR) growing faster than total revenue.[1][6][7] This is reinforced by a strong dollar‑based net retention rate and multi‑year contracts with government and law‑enforcement agencies, which tend to be sticky once embedded in workflows.[1] The moat benefits from specialized technology, entrenched relationships with investigative bodies, and accumulated datasets and workflows that are hard for competitors to replicate. Leadership has navigated the transition to SaaS, executed bolt‑on M&A, and scaled profitability, suggesting capable management with a clear strategic roadmap.[1][6][7]

What the Company Does

Cellebrite DI provides digital intelligence and investigative solutions that help law‑enforcement, government agencies, and enterprises collect, analyze, and manage digital evidence from mobile devices, computers, cloud services, and other data sources.[9] Its software and services streamline the end‑to‑end investigative process, from data extraction to analytics and case management, increasingly leveraging AI to surface insights and patterns.[9]

The company primarily makes money by selling software subscriptions and related services for its digital forensics and investigative platforms.[1][7] Management has indicated that software solutions account for the vast majority of revenue, with cloud, SaaS, and analytics becoming a larger share over time.[7] The mix is heavily skewed toward recurring software and SaaS, supplemented by professional services and some hardware or on‑premise components.[1][7]

Revenue Recurrence & Predictability

Cellebrite’s revenue is predominantly subscription‑based and contractual, billed through SaaS and term licenses that provide ongoing access to its platforms.[1][7] Recent disclosures show subscription revenue comprises nearly all of total revenue, and ARR is a key management focus, signaling a classic recurring‑revenue software model rather than a project‑driven services business.[1][6]

The company also reports a strong recurring revenue net retention rate, indicating that existing customers are expanding usage faster than they churn.[1] Combined with multi‑year contracts, especially in the public sector, this creates a high degree of visibility and predictability in forward revenue. Transactional or one‑off projects appear secondary, mainly in services tied to implementation, training, or specialized investigative support.[7]

Revenue Growth Durability

Cellebrite operates in a large and structurally expanding total addressable market driven by the proliferation of digital data, encrypted devices, and cloud services in criminal and civil investigations.[6][7] Law‑enforcement agencies globally are still in the early to mid stages of adopting advanced digital intelligence tools, leaving meaningful runway for penetration and seat expansion. The company is also pushing deeper into analytics, cloud, and AI‑powered capabilities, which broaden its role in the investigative stack.[7]

Growth levers include upselling current customers to cloud and analytics modules, expanding geographically, and selling into adjacent segments such as corporate investigations and private‑sector security teams.[6][7] Structural tailwinds—more complex digital evidence, rising regulatory and compliance expectations, and increasing cybercrime—support sustained above‑market growth. Headwinds include budget cycles and procurement delays in government and law‑enforcement, as well as FX impacts given its international footprint.[1][7]

Economic Moat

Cellebrite’s moat rests on specialized technology, entrenched customer relationships, and intangible know‑how in digital forensics and intelligence. Its tools are integrated into critical investigative workflows, and agencies invest in training, procedures, and policies around its platforms, creating meaningful switching costs.[6][7] The company’s long history in mobile device extraction and cross‑platform data handling has produced proprietary techniques and product depth that are hard for newer entrants to match.

As Cellebrite shifts more of its offering to cloud and AI‑driven analytics, its moat may be widening through network and data advantages, since insights improve as more cases and datasets flow through the system.[6][9] However, the moat is contested: competitors in digital forensics, cybersecurity, and analytics are investing heavily, and some large platform vendors may try to move up into adjacent investigative use cases. For now, Cellebrite’s focus, brand recognition in law‑enforcement, and product breadth give it a defensible position.[7]

Management & Leadership

Cellebrite is not founder‑led; it is part of the broader Cellebrite group that developed digital forensics tools over many years and later listed as Cellebrite DI.[6][7] The current leadership team has overseen the transition toward SaaS and cloud, a focus on ARR, and the scaling of profitability and free cash flow, indicating operational discipline and a willingness to evolve the business model.[1][6]

Management has also used targeted acquisitions, such as Corellium, to strengthen its technology stack and broaden capabilities in areas like virtualized device environments.[7] Insider ownership appears meaningful but not controlling, aligning leadership with long‑term value creation while leaving room for institutional oversight. Recent capital allocation emphasizes reinvestment in product, selective M&A, and maintaining a strong cash position rather than aggressive leverage.[1][7]

Key Risks

The most significant risk is regulatory and reputational. Cellebrite’s tools are powerful, and their use by governments and law‑enforcement agencies can attract scrutiny over privacy, civil liberties, and human rights. Changes in regulations around device access, encryption, or digital evidence handling could constrain product capabilities or require costly adaptations, while reputational issues could complicate customer relationships and procurement.[6][7]

A second risk is competitive and technological. The digital forensics and intelligence space includes specialized competitors and larger security or analytics vendors that may integrate similar capabilities into broader platforms.[7] Rapid shifts in device architecture, operating systems, and encryption methods demand continuous R&D; failure to keep pace could erode Cellebrite’s technical edge and weaken its value proposition.

Finally, there is customer and budget concentration risk. A large portion of revenue is tied to government and law‑enforcement budgets, which are subject to political decisions, fiscal constraints, and lengthy procurement cycles.[1][7] A slowdown in public‑sector spending, a shift in investigative technology priorities, or the loss of a major agency contract could materially affect growth, even if the broader demand for digital intelligence remains strong.

Sources

  1. https://investors.cellebrite.com/news-releases/news-release-details/cellebrite-announces-first-quarter-2026-results
  2. https://finance.yahoo.com/news/cellebrite-di-q4-earnings-call-175240769.html
  3. https://investors.cellebrite.com/static-files/288697a6-803a-43c8-8d26-e5a07aad9f92
  4. https://www.marketwatch.com/story/cellebrite-di-shares-rise-after-swing-to-profit-in-3q-higher-revenue-dccf77e6
  5. https://public.com/stocks/clbt/earnings
  6. https://www.investing.com/news/transcripts/earnings-call-transcript-cellebrite-q1-2026-beats-forecasts-stock-rises-93CH-4699246
  7. https://www.aol.com/articles/cellebrite-clbt-q4-2025-earnings-150239784.html
  8. https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/past
  9. https://www.stocktitan.net/news/CLBT/cellebrite-to-report-second-quarter-2026-financial-results-on-august-bzczwfcziov8.html

Featured in GreenDot Stocks Analysis